CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

September 30, 2009

Conditions
Antiphospholipid Antibody Syndrome
Interventions
DRUG

Celecoxib

celecoxib 200mg/day by oral rout during 15 days followed by the administration of rofecoxib 25mg/day, acetaminophen 3g/day and placebo during 15 days each drug.

DRUG

Acetaminophen

Acetaminophen 3g/ was given during 15 days by oral rout following one of the other interventions or as the final intervention.

DRUG

Rofecoxib

Rofecoxib 25mg/day was given by oral rout during 15 days following one or more interventions or as the final intervention.

DRUG

placebo

Placebo pills were given during 15 days by oral rout as one of the four interventions.

All Listed Sponsors
lead

Hospital Universitario Pedro Ernesto

OTHER

NCT01762891 - CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen | Biotech Hunter | Biotech Hunter